Throughout many countries and jurisdictions, the common way of testing for bioequivalence is to compare the pharmacokinetics of the new formulation (“test”) with that of the known formulation (“reference”). Bioequivalence testing is a general requirement for companies developing generic medicines, testing food effects, making formulation changes, or developing extensions to existing approved medicines where absorption rate and extent to the systemic circulation determines safety and efficacy.
0 kommentar(er)
